Greenberger P A, Patterson R, Radin R C
J Allergy Clin Immunol. 1984 Oct;74(4 Pt 1):540-3. doi: 10.1016/0091-6749(84)90391-9.
The risk of anaphylactoid reaction (AR) developing from radiographic contrast media in patients who previously have had an AR to radiographic contrast media ranges from 17% to 60%. Pretreatment with prednisone plus diphenhydramine or prednisone and diphenhydramine plus ephedrine decreased the reaction rate to 9.0% and 3.1%, respectively, during 657 procedures in 563 patients. No deaths occurred, and only three episodes of transient hypotension developed, one of which was treated with epinephrine. Pretreatment consisted of prednisone, 50 mg, 13 hr, 7 hr, and 1 hr before the procedure and diphenhydramine, 50 mg, 1 hr and or ephedrine, 25 mg, 1 hr before the procedure. The addition of ephedrine provided a statistically significant reduction in reaction in 192 procedures (chi 2 = 5.4996, p = 0.019). In 138 procedures in patients whose initial AR was considered serious, pretreatment was as effective as for patients with histories of mild to moderate reactions. Emergency equipment should be available for all procedures.
既往对放射造影剂有过敏样反应(AR)的患者,因放射造影剂发生AR的风险为17%至60%。在563例患者的657例检查中,使用泼尼松加苯海拉明或泼尼松、苯海拉明加麻黄碱进行预处理后,反应率分别降至9.0%和3.1%。未发生死亡,仅出现3例短暂性低血压,其中1例用肾上腺素治疗。预处理方案为:泼尼松50mg,在检查前13小时、7小时和1小时服用;苯海拉明50mg,在检查前1小时服用;和/或麻黄碱25mg,在检查前1小时服用。在192例检查中,添加麻黄碱使反应率显著降低(χ² = 5.4996,p = 0.019)。在138例初始AR被认为严重的患者检查中,预处理的效果与轻度至中度反应病史患者相同。所有检查均应配备急救设备。